Jurriën Prins

Founder

Jurriën finished his study Biomedical Sciences at Leiden University and started his PhD at the department of Internal Medicine (Nephrology) at the Leiden University Medical Center. During this time, Jurriën studied the role of RNA-binding proteins and RNA processing in cardiovascular disease, as well as the development of various RNA-based therapeutic modalities. He is currently working as a post-doctoral researcher, combining a bio-informatics approach with experimental lab work to further the development of an antiviral antisense therapy.